ロード中...
Hydroxyurea for sickle cell anemia: What have we learned and what questions still remain?
PURPOSE OF REVIEW: Sickle cell anemia (SCA) is a well-characterized severe hematological disorder with substantial morbidity and early mortality. Hydroxyurea is a potent inducer of fetal hemoglobin, and evidence over the past 25 years has documented its laboratory and clinical efficacy for both adul...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181131/ https://ncbi.nlm.nih.gov/pubmed/21372708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e32834521dd |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|